tradingkey.logo
搜索

WAVE Life Sciences Ltd

WVE
添加自选
5.510USD
-0.250-4.34%
收盘 07-31 16:00美东报价延迟15分钟
1.09B总市值
亏损市盈率 TTM

关于 WAVE Life Sciences Ltd 公司

Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company’s RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company’s diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington’s disease, as well as several preclinical programs utilizing the Company’s broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).

WAVE Life Sciences Ltd简介

公司代码WVE
公司名称WAVE Life Sciences Ltd
上市日期Nov 11, 2015
CEOBolno (Paul B)
员工数量287
证券类型Ordinary Share
年结日Nov 11
公司地址7 Straits View
城市
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Singapore
邮编018936
电话6562363388
网址https://www.wavelifesciences.com/
公司代码WVE
上市日期Nov 11, 2015
CEOBolno (Paul B)

WAVE Life Sciences Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Chandra Vargeese, Ph.D.
Dr. Chandra Vargeese, Ph.D.
Chief Technology Officer, Head - Platform Discovery Sciences
Chief Technology Officer, Head - Platform Discovery Sciences
334.87K
-2.94%
Mr. Kyle Moran
Mr. Kyle Moran
Chief Financial Officer
Chief Financial Officer
57.26K
-79.88%
Dr. Christopher I. Wright, M.D., Ph.D.
Dr. Christopher I. Wright, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
45.63K
--
Ms. Heidi L. Wagner, J.D.
Ms. Heidi L. Wagner, J.D.
Independent Director
Independent Director
16.11K
-78.81%
Mr. Ken Takanashi
Mr. Ken Takanashi
Independent Director
Independent Director
11.24K
-112.96%
Dr. Christopher John Francis, Ph.D.
Dr. Christopher John Francis, Ph.D.
Senior Vice President - Corporate Development, Head - Emerging Areas
Senior Vice President - Corporate Development, Head - Emerging Areas
4.37K
-744.22%
Dr. Paul B. Bolno, M.D.
Dr. Paul B. Bolno, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Gregory L. (Greg) Verdine, Ph.D.
Dr. Gregory L. (Greg) Verdine, Ph.D.
Director
Director
--
--
Dr. Peter Kolchinsky, Ph.D.
Dr. Peter Kolchinsky, Ph.D.
Independent Director
Independent Director
--
--
Mr. Christian O. Henry
Mr. Christian O. Henry
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Chandra Vargeese, Ph.D.
Dr. Chandra Vargeese, Ph.D.
Chief Technology Officer, Head - Platform Discovery Sciences
Chief Technology Officer, Head - Platform Discovery Sciences
334.87K
-2.94%
Mr. Kyle Moran
Mr. Kyle Moran
Chief Financial Officer
Chief Financial Officer
57.26K
-79.88%
Dr. Christopher I. Wright, M.D., Ph.D.
Dr. Christopher I. Wright, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
45.63K
--
Ms. Heidi L. Wagner, J.D.
Ms. Heidi L. Wagner, J.D.
Independent Director
Independent Director
16.11K
-78.81%
Mr. Ken Takanashi
Mr. Ken Takanashi
Independent Director
Independent Director
11.24K
-112.96%
Dr. Christopher John Francis, Ph.D.
Dr. Christopher John Francis, Ph.D.
Senior Vice President - Corporate Development, Head - Emerging Areas
Senior Vice President - Corporate Development, Head - Emerging Areas
4.37K
-744.22%

常见问题

WAVE Life Sciences Ltd的前五大股东是谁?

WAVE Life Sciences Ltd 的前五大股东如下:Dr. Chandra Vargeese, Ph.D.
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有